MedaSync
PrivateLast Round
Strategic
Aug 27, 2025
Total Funding Raised
$570,000
Momentum Score
25 /100
Company Overview
MedaSync is a healthcare technology company that provides an AI-powered reimbursement optimization software for skilled nursing facilities (SNFs). Its cloud-based platform uses custom AI-audits to analyze clinical documentation, proactively identifying reimbursement misalignments and shifting patient needs to ensure quality care. The software is designed to enhance an operator's reimbursement mix across various payers, including Medicare, Medicaid CMI, QIP performance, and Medicare Advantage. The company's goal is to reduce administrative burdens, allowing care providers to focus more on patient care.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Vertical SaaS, Medical AI, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedaSync Comps
Public and private peers based on sector, stage, and business model.
MedaSync Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 27, 2025 | ||||
| Pre Seed | Jul 31, 2018 | ||||
| Grant | Jan 27, 2017 |
MedaSync Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Valley Growth Ventures | Pre Seed |
| Youngstown Business Incubator | Grant |
| Burton D. Morgan Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
Megan Krull joins the Board of Directors.
MedaSync Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MedaSync's valuation, stock price, and market status.
